Procter & Gamble stock slipped about 1.5% today, even though the earnings story looks more like a grind on margins than a collapse in fundamentals. The company closed with a trailing P/E of 20.9x and a dividend yield near 3%, while the latest quarter showed Basic EPS of US$1.28 on revenue of US$21,203m.

The real flashpoint for sentiment is profit pressure. Core gross margin for the year moved slightly lower and core operating margin compressed further. The market is reacting to that squeeze, not a revenue shock. This sets up a debate over how patient investors may want to be with Procter & Gamble’s earnings power.

Is Procter & Gamble trading at a sensible discount given its 20.9x P/E and margin squeeze, or is the market glossing over real earnings risk? Compare today's share price to our valuation analysis for Procter & Gamble

FY 2026 Earnings Summary

• Revenue, Q4 FY 2026 vs. Q4 FY 2025: US$21,203m vs. US$20,889m (modest year on year increase)
• Net Income, Q4 FY 2026 vs. Q4 FY 2025: US$3,044m vs. US$3,539m (declined year on year)
• Basic EPS, Q4 FY 2026 vs. Q4 FY 2025: US$1.28 vs. US$1.48 (declined year on year)
• Net Profit Margin, TTM Q4 FY 2026 vs. TTM Q4 FY 2025: 18.4% vs. 18.6% (slight margin compression)

Prefer clear charts instead of another dense block of earnings tables and margin figures? Get a full visual view of Procter & Gamble’s valuation story in the company report for Procter & Gamble.

Procter & Gamble bull case meets mixed proof

Bulls argue that Procter & Gamble can grow earnings per share through steady organic growth, productivity and rich capital returns even when demand is sluggish. Fiscal 2026 partly supports that story. Organic sales rose about 1% with modest volume growth and core EPS reached US$6.89, and the company returned more than US$15b to shareholders while keeping adjusted free cash flow productivity at 100%. Productivity savings of US$2.8b before tax and strong Q4 efficiency gains show that AI, Supply Chain 3.0 and restructuring are delivering measurable cost benefits. Market share exited the year flat with some improvement in the second half, which fits the “foundation building” narrative. The bull case, however, requires margin expansion. Core gross margin declined about 40 basis points and core operating margin declined about 70 basis points, so earnings resilience is coming more from financial discipline than from stronger underlying profitability.

Bear case on margins and demand gains traction

Bears focus on slowing growth, cost inflation and the risk that restructuring and AI programs do not fully protect margins. Recent results give that view some support. Q4 revenue of US$21.2b came with flat organic growth and a decline in net income from US$3,539m to US$3,044m and Basic EPS from US$1.48 to US$1.28. Core gross and operating margins compressed for the year despite sizeable productivity savings, and Q4 operating margin fell 130 basis points as energy, transport and material costs hit earnings, only partly balanced by tariff refunds. Fiscal 2027 guidance also leans cautious. Management is planning for a US$1.4b after tax headwind from commodities, FX and financing, and expects Q1 EPS to be down at least 5%. The share price has slipped around 1.5% today and is down over the past 30, 90 and 7 days, which shows investors are treating these pressures as more than a one quarter issue.

After margin compression, energy and material cost pressure, and a cautious outlook, you may want to review whether this is only the visible part of Procter & Gamble’s risk profile. Scan the independent risk analysis for Procter & Gamble which shows 1 important warning sign

Take Control of Your Next Move

If the recent margin squeeze and cautious outlook at Procter & Gamble has you watching for a better entry point, register for free with Simply Wall St and add it to a Watchlist so you can track the share price against fair value before committing fresh capital. After you invest, use the Portfolio Command Center to cut through market noise and focus on the updates that matter most to your holdings. For a longer term view, tap into crowd insights and debate the Procter & Gamble story inside the Community. By spotting potential catalysts and risks early, you give yourself a better chance to stay ahead of market moves and act with confidence.

Curious About Smart Alternatives To Procter & Gamble

Fresh stock ideas can move from quiet momentum to full breakout faster than most investors expect. Scan these under the radar for now opportunities before the crowd, act now.

• Spot income workhorses that aim to keep paying you while markets shift by scanning the curated 8 dividend fortresses before yields get caught dropping.
• Hunt for resilient companies where balance sheets and cash flows still look solid by running the focused list of solid balance sheet and fundamentals stocks (46 results) while these stocks fly under the radar.
• Track early moves in quantum computing as adoption builds by reviewing the hand picked 26 quantum computing stocks before momentum traders rush in.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.